Spotlight

August 30, 2021

SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients with Hypertension at Medium to Very High Risk

Stéphane Laurent and colleagues compared a therapeutic strategy targeting pulse wave velocity (PWV) with a conventional strategy for treating hypertension. The study enrolled 536 participants and […]

Do you like it?

SphygmoCor by the Numbers

Top 20

All “Top 20 Hospitals” use SphygmoCor technology to measure central blood pressure (cBP)

2,400+

SphygmoCor technology has supported studies that have resulted in over 2,400+ peer-reviewed publications.

8/10

8 out of top 10 Pharma companies have used SphygmoCor technology in their clinical trials

11,000

Over 11,000 patients have been tested with SphygmoCor technology in pharmaceutical trials

Company

About
Board & Management
Corporate Governance
News & Media
Events & Tradeshows
Careers

Legal

Privacy Policy
Disclaimer
Acceptable Use Policy

SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients with Hypertension at Medium to Very High Risk

No results See all results

Get in Touch

If you are an existing customer that needs assistance, please visit our Customer Portal.

CARDIEX IS NOW

Top Five 2025 Trends Shaping the Future of Clinical Development

We appreciate your patience as we transition to our new future! In the meantime you can visit us here

This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.